These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 773605)

  • 61. [Bacteriological and clinical evaluation of a dicloxacillin-ampicillin combination (author's transl)].
    Abbate GF; Leonessa V; Altucci P
    Arzneimittelforschung; 1978; 28(6):1008-13. PubMed ID: 581996
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Penetration of ciclacillin into bronchial secretions.
    Bone M; Symonds J; Dougan P
    Chemioterapia; 1986 Apr; 5(2):105-8. PubMed ID: 3708715
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Sensitivity of bacteria inducing urinary infections to 3 drugs (amoxicillin, ampicillin and cephalexin) and clinical efficacy of amoxicillin (author's transl)].
    Fukushima S; Fujii H; Kitajima N; Suzuki M
    Jpn J Antibiot; 1975 Dec; 28(6):795-801. PubMed ID: 1104914
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract].
    Bogdanov MB; Chernen'kaia TV
    Antibiot Khimioter; 2000; 45(10):15-8. PubMed ID: 11212394
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A study of antibacterial activity of furbenicillin against beta-lactamase producing gram-negative organisms.
    Yang YJ; Li JT
    Chin Med J (Engl); 1984 May; 97(5):345-51. PubMed ID: 6439485
    [No Abstract]   [Full Text] [Related]  

  • 68. Intestinal absorption mechanism of amphoteric beta-lactam antibiotics II: Michaelis-Menten kinetics of cyclacillin absorption and its pharmacokinetic analysis in rats.
    Tsuji A; Nakashima E; Kagami I; Yamana T
    J Pharm Sci; 1981 Jul; 70(7):772-7. PubMed ID: 7264925
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is cyclacillin really better?
    Marks MI
    J Pediatr; 1983 Aug; 103(2):341. PubMed ID: 6875740
    [No Abstract]   [Full Text] [Related]  

  • 70. [Influence of steric hindrance on the degradation of ciclacillin and ampicillin (author's transl)].
    Moll F; von der Mark L
    Arch Pharm (Weinheim); 1981 Oct; 314(10):823-31. PubMed ID: 7305638
    [No Abstract]   [Full Text] [Related]  

  • 71. Microbiological and pharmacological evaluation, in mice and rats, of a new nitrofuran: 2-amino-4-methyl-6-(2-ethinyl-5-nitrofuryl)-pyrimidine (nifurpyrimidine).
    Castelli M; Genedani S; Bertolini A
    Chemotherapy; 1979; 25(2):91-5. PubMed ID: 446189
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Kinetics of Michaelis-Menten absorption of amino-penicillins in rats.
    Tsuji A; Nakashima E; Kagami I; Asano T; Nakashima R; Yamana T
    J Pharm Pharmacol; 1978 Aug; 30(8):508-9. PubMed ID: 28400
    [No Abstract]   [Full Text] [Related]  

  • 73. Metabolic and pathologic investigation of 1-aminocyclohexanecarboxylic acid (ACHC), a metabolite of 6-(1-aminocyclohexanecarboxamido)-penicillanic acid (cyclacillin).
    Janssen FW; Young EM; Kirkman SK; Agersborg HP; Tucker WE; Ruelius HW
    Toxicol Appl Pharmacol; 1974 Jul; 29(1):19-34. PubMed ID: 4378191
    [No Abstract]   [Full Text] [Related]  

  • 74. Substituted ampicillins.
    Wise R
    J Antimicrob Chemother; 1977 Jul; 3(4):289-90. PubMed ID: 893236
    [No Abstract]   [Full Text] [Related]  

  • 75. A new spectrophotometric method for the selective determination of ampicillin, amoxycillin and cyclacillin in the presence of polymers and other degradation products.
    Bundgaard H; Larsen C
    J Pharm Biomed Anal; 1983; 1(1):29-37. PubMed ID: 16867831
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microbiological studies on a new broad-spectrum penicilin, "Penbritin".
    ROLINSON GN; STEVENS S
    Br Med J; 1961 Jul; 2(5246):191-6. PubMed ID: 13742934
    [No Abstract]   [Full Text] [Related]  

  • 77. Sex- and species-related nephropathy of 6-(1-aminocyclohexanecarboxamido)penicillanic acid (cyclacillin) and its relationship to the metabolic disposition of the drug.
    Tucker WE; Janssen FW; Agersborg HP; Young EM; Ruelius HW
    Toxicol Appl Pharmacol; 1974 Jul; 29(1):1-18. PubMed ID: 4283678
    [No Abstract]   [Full Text] [Related]  

  • 78. Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.
    Olsson B; Dornbusch K; Nord CE
    Med Microbiol Immunol; 1977 Oct; 163(3):183-94. PubMed ID: 243112
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal.
    Warren GH
    Chemotherapy; 1976; 22(3-4):154-82. PubMed ID: 773605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cyclacillin (cyclapen)--another new penicillin.
    Med Lett Drugs Ther; 1980 Feb; 22(3):13-4. PubMed ID: 6986544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.